Market revenue in 2023 | USD 26.1 million |
Market revenue in 2030 | USD 55.4 million |
Growth rate | 11.4% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Kits & Reagents, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Lonza Group Ltd, Merck KGaA, Charles River Laboratories International Inc, Asahi Kasei Corp, Sartorius AG, Eurofins Scientific SE, PromoCell GmbH, ATCC, InvivoGen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mycoplasma testing market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 55.94% in 2023. Horizon Databook has segmented the Brazil mycoplasma testing market based on instruments, kits & reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil is anticipated to be one of the most lucrative markets for mycoplasma testing products in Latin America. This dominance can be attributed to the presence of an established pharmaceutical industry compared to other Latin American countries. Stem cell research in Brazil has exhibited significant growth in the past decade.
For instance, over 130,000 scientists are conducting research in the country, with over 250 associated with the Brazilian Association for Cell Therapy. With increasing research activities and a strong pipeline of biopharmaceuticals, there is a continuous demand for quality control protocols, which is expected to fuel the market for mycoplasma testing over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil mycoplasma testing market , including forecasts for subscribers. This country databook contains high-level insights into Brazil mycoplasma testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account